FDA approves Analog and Dipharma’s ANDA for nitisinone capsules
Pharmaceutical Technology
JUNE 1, 2023
Nitisinone capsules are indicated for the treatment of adult and paediatric patients with HT-1 in combination with dietary restriction of tyrosine and phenylalanine. Some of the most common side effects of nitisinone include low platelet count, elevated tyrosine levels, eye pain, white or cloudy cornea from scarring, and pink eye.
Let's personalize your content